Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
IPO Year: 2021
Exchange: NASDAQ
Website: priviahealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/11/2024 | $23.00 | Overweight | KeyBanc Capital Markets |
| 5/30/2024 | $23.00 | Outperform | Robert W. Baird |
| 4/22/2024 | $25.00 | Buy | Citigroup |
| 3/6/2024 | $22.00 | Equal Weight | Barclays |
| 2/26/2024 | $33.00 → $25.00 | Buy | Jefferies |
| 2/22/2024 | $21.00 | Buy → Neutral | BofA Securities |
| 12/6/2023 | $27.00 | Mkt Outperform | JMP Securities |
| 6/13/2023 | $34.00 | Outperform | Evercore ISI |
| 4/12/2023 | $33.00 | Overweight | Stephens |
| 3/10/2023 | $36.00 | Outperform | RBC Capital Mkts |
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared Saving of $176.6 Million, +34.1% versus 2023Strong Adjusted EBITDA Growth and Free Cash Flow Generation ARLINGTON, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the third quarter and nine months ended September 30, 2024. Third Quarter Performance For the Three Months Ended September 30, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $437.9 $417.3 4.9%Gross profit $99.9 $90.6 10
ARLINGTON, Va., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that its Accountable Care Organizations (ACOs) achieved shared savings of $176.6 million through the Medicare Shared Savings Program (MSSP) for the 2023 performance year, a 34.1% increase from 2022. The 10 ACOs (collectively, Privia Quality Network or PQN) managed over $2.3 billion in healthcare benchmark spend through approximately 2,850 providers delivering high-value, cost-efficient care to 194,786 Medicare beneficiaries in 2023. "The success of Privia Quality Network in MSSP is a testament to the dedication and skill of our doctors, who provided exceptional care to nearly 195,000
ARLINGTON, Va., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its third quarter and nine-month periods ended September 30, 2024 before market open on Thursday, November 7, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, November 7, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-e
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to Mid to High End for All Metrics ARLINGTON, Va., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the second quarter and six months ended June 30, 2024. Second Quarter Performance For the Three Months Ended June 30, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $422.3 $413.4 2.2%Gross profit $98.3 $90.2 8.9%Operating income $5.1 $7.0 (27.0)%Net income a $3.5 $7.3 (52.3)%Non-GAAP adjusted net income b $23.5 $20.8 13.0%Net income per share $0.03 $0.06 (50.0)%Non-GAAP adjusted net income per sh
ARLINGTON, Va., July 11, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it plans to release financial results for its second quarter and six-month periods ended June 30, 2024 before market open on Thursday, August 8, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, August 8, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/event
ARLINGTON, Va., June 25, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that its network of affiliated medical groups, collectively Privia Medical Group, has been named a recipient of the 2024 MAP Award for High Performance in Revenue Cycle, sponsored by the Healthcare Financial Management Association (HFMA). Privia has been recognized by HFMA for its revenue cycle capabilities and performance in eight of the last nine years. As a national award winner, Privia has met industry-standard revenue cycle benchmarks, implemented the patient-centered recommendations and best practices embodied in HFMA's Healthcare Dollars & Sense® initiatives, and achieved outstandi
ARLINGTON, Va., May 30, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that its management team plans to present at the 44th Annual William Blair Growth Stock Conference on Wednesday, June 5, 2024, beginning at 11:00 am ET / 10:00 am CT. The live webcast and replay of the event will be available at ir.priviahealth.com/news-and-events/events-and-presentations. About Privia Health Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-p
Practice Collections +7.4% compared to 1Q'23Implemented Providers +17.3% compared to 1Q'23Company Reiterated Full Year 2024 Guidance ARLINGTON, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the first quarter ended March 31, 2024. For the Three Months Ended March 31, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue$ 415.2 $ 386.3 7.5 %Gross profit$ 93.4 $ 83.0 12.5 %Operating income$ 0.8 $ 6.7 (87.7)%Net income a$ 3.0 $ 7.3 (59.3)%Non-GAAP adjusted net income b$ 22.5 $
ARLINGTON, Va., April 09, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it plans to release financial results for its first quarter ended March 31, 2024 before market open on Thursday, May 9, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, May 9, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/events-and-presentations to list
Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements in Current Medicare Advantage Environment for More Favorable Contract Structures and Margin Contribution ARLINGTON, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2023. The Company achieved each of its full-year guidance metrics for 2023, as highlighted below. Full-Year Performance For the Years Ended December 31, ($ in millions, except per sh
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G - Privia Health Group, Inc. (0001759655) (Subject)
KeyBanc Capital Markets initiated coverage of Privia Health with a rating of Overweight and set a new price target of $23.00
Robert W. Baird initiated coverage of Privia Health with a rating of Outperform and set a new price target of $23.00
Citigroup initiated coverage of Privia Health with a rating of Buy and set a new price target of $25.00
Barclays initiated coverage of Privia Health with a rating of Equal Weight and set a new price target of $22.00
Jefferies resumed coverage of Privia Health with a rating of Buy and set a new price target of $25.00 from $33.00 previously
BofA Securities downgraded Privia Health from Buy to Neutral and set a new price target of $21.00
JMP Securities initiated coverage of Privia Health with a rating of Mkt Outperform and set a new price target of $27.00
Evercore ISI initiated coverage of Privia Health with a rating of Outperform and set a new price target of $34.00
Stephens initiated coverage of Privia Health with a rating of Overweight and set a new price target of $33.00
RBC Capital Mkts initiated coverage of Privia Health with a rating of Outperform and set a new price target of $36.00
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared Saving of $176.6 Million, +34.1% versus 2023Strong Adjusted EBITDA Growth and Free Cash Flow Generation ARLINGTON, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the third quarter and nine months ended September 30, 2024. Third Quarter Performance For the Three Months Ended September 30, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $437.9 $417.3 4.9%Gross profit $99.9 $90.6 10
ARLINGTON, Va., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its third quarter and nine-month periods ended September 30, 2024 before market open on Thursday, November 7, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, November 7, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-e
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to Mid to High End for All Metrics ARLINGTON, Va., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the second quarter and six months ended June 30, 2024. Second Quarter Performance For the Three Months Ended June 30, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $422.3 $413.4 2.2%Gross profit $98.3 $90.2 8.9%Operating income $5.1 $7.0 (27.0)%Net income a $3.5 $7.3 (52.3)%Non-GAAP adjusted net income b $23.5 $20.8 13.0%Net income per share $0.03 $0.06 (50.0)%Non-GAAP adjusted net income per sh
ARLINGTON, Va., July 11, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it plans to release financial results for its second quarter and six-month periods ended June 30, 2024 before market open on Thursday, August 8, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, August 8, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/event
Practice Collections +7.4% compared to 1Q'23Implemented Providers +17.3% compared to 1Q'23Company Reiterated Full Year 2024 Guidance ARLINGTON, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the first quarter ended March 31, 2024. For the Three Months Ended March 31, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue$ 415.2 $ 386.3 7.5 %Gross profit$ 93.4 $ 83.0 12.5 %Operating income$ 0.8 $ 6.7 (87.7)%Net income a$ 3.0 $ 7.3 (59.3)%Non-GAAP adjusted net income b$ 22.5 $
ARLINGTON, Va., April 09, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it plans to release financial results for its first quarter ended March 31, 2024 before market open on Thursday, May 9, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, May 9, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/events-and-presentations to list
Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements in Current Medicare Advantage Environment for More Favorable Contract Structures and Margin Contribution ARLINGTON, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2023. The Company achieved each of its full-year guidance metrics for 2023, as highlighted below. Full-Year Performance For the Years Ended December 31, ($ in millions, except per sh
ARLINGTON, Va., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it plans to release financial results for its fourth quarter and full year ended December 31, 2023 before market open on Tuesday, February 27, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Tuesday, February 27, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/event
Practice Collections +18.2% compared to 3Q'22Implemented Providers +14.2% compared to 3Q'22Company Updated Full Year 2023 Guidance ARLINGTON, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the third quarter and nine month periods ended September 30, 2023. Third Quarter Total revenue for the third quarter of 2023 was $417.3 million, compared to total revenue of $342.9 million for the prior year third quarter (+21.7%). Gross Profit for the third quarter of 2023 was $90.6 million, compared to $76.9 million for the prior year third quarter. Operating income for the third quarter of 2023 was $5.5 million, compared to
ARLINGTON, Va., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it plans to release financial results for its third quarter and nine-month periods ended September 30, 2023 before market open on Friday, November 3, 2023. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Friday, November 3, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-eve
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
S-8 - Privia Health Group, Inc. (0001759655) (Filer)
10-Q - Privia Health Group, Inc. (0001759655) (Filer)
8-K - Privia Health Group, Inc. (0001759655) (Filer)
10-Q - Privia Health Group, Inc. (0001759655) (Filer)
8-K - Privia Health Group, Inc. (0001759655) (Filer)
8-K - Privia Health Group, Inc. (0001759655) (Filer)
8-K - Privia Health Group, Inc. (0001759655) (Filer)
8-K/A - Privia Health Group, Inc. (0001759655) (Filer)
8-K - Privia Health Group, Inc. (0001759655) (Filer)
10-Q - Privia Health Group, Inc. (0001759655) (Filer)
ARLINGTON, Va., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today. Mr. Fargis will serve as the Company's chief legal officer, working with Privia executive leadership to support the Company's long-term direction and growth. "Ed is a proven leader who brings an invaluable healthcare industry perspective as well as extensive experience managing corporate governance, compliance and strategic transactions," said Parth Mehrotra, CEO, Privia Health. "As Privia continues to grow and our industry evolves, we are fortunate to have Ed joining us
ARLINGTON, Va., April 12, 2023 (GLOBE NEWSWIRE) -- Privia Health (NASDAQ:PRVA), a technology-driven, national physician enablement company, today announced that Parth Mehrotra, currently the Company's President and Chief Operating Officer, has been named Chief Executive Officer, effective July 1, 2023. Mehrotra is succeeding current CEO, Shawn Morris, who is retiring and will remain on the Company's Board of Directors. Under Morris' leadership since early 2018, Privia Health progressed from a private, regional organization into a publicly-traded company with national reach. During that time, the Company entered eight new states, completed a successful IPO in April 2021, and increased it
Analysts' ratings for Privia Health Gr (NASDAQ:PRVA) over the last quarter vary from bullish to bearish, as provided by 7 analysts. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 2 1 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 2 1 1 0 0 3M Ago 2 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $23.0, along with a high estimate of $26.00 and a low estimate of $19.00. This current average represents a 16.67% de
Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and lowers the price target from $23 to $20.
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga’s insider transactions platform. Privia Health Group The Trade: Privia Health Group, Inc. (NASDAQ:PRVA) Director Adam Boehler acquired a total of 4,280 sha
Baird analyst Michael Ha initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Outperform rating and announces Price Target of $23.
Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and lowers the price target from $22 to $19.
Ratings for Privia Health Gr (NASDAQ:PRVA) were provided by 12 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 7 3 2 0 0 Last 30D 1 0 0 0 0 1M Ago 3 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 2 3 2 0 0 Analysts have set 12-month price targets for Privia Health Gr, revealing an average target of $26.42, a high estimate of $37.00, and a low estimate of $21.00. A negative shift in sentiment is evident as analysts have de
Truist Securities analyst Jailendra Singh maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $28 to $24.
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $37 to $26.